Blood Culture Tests Market Size is Expected to Reach USD 9.51 Billion in 2030 – Reports and Data
The global blood culture tests market size was USD 4.35 Billion in 2021 and is expected to register a revenue CAGR of 9.1% over the forecast period, according to the latest report by Reports and Data. Market revenue growth is expected to be driven due to the increasing prevalence of infectious diseases, Bloodstream Infections (BSIs), and sepsis.
Bloodstream Infection (BSI) is one of the most serious illnesses with a high mortality rate and morbidity rate. Depending on the institution and the ICU within a hospital, nosocomial BSIs differ in their occurrence, epidemiology, and microbiological profile. It is important to recognize the microbes that cause BSIs and antibiotic resistance, and each hospital or lab setting should make its own therapeutic decisions based on local monitoring data. Rising number of blood tests is being conducted by healthcare providers owing to a rise in bloodstream infections, which is increasing the demand for blood culture tests. The growing incidence and death rate of sepsis is expected to increase adoption of bloodstream infection testing. In addition, increasing incidences of infectious diseases will increase bloodstream infection testing, resulting in market revenue growth during the forecast period.
To get a sample copy of the report, click on @ https://www.reportsanddata.com/download-free-sample/1461
Top Companies Profiled in the Report:
- DiaSorin S.p.A
- Hoffmann-La Roche Ltd.
- T2 Biosystems Inc.
- Thermo Fisher Scientific Inc.
- Scenker Biological Technology Co. Ltd
- Anaerobe Systems Inc.
- BINDER GmbH
- Mycobacterial detection
The global pharma & healthcare market revenue growth majorly driven by factors such as increasing prevalence of chronic and acute illnesses around the world, substantially growing patient pool, rise in demand for personalized medicine, increasing pharmaceutical and biotechnological research & development projects, and rapid incorporation of emerging technologies such as artificial intelligence (AI), Internet of Things (IoT), big data analytics, robotics, and blockchain in healthcare. Rising cases of COVID-19 worldwide, surge in demand for advanced healthcare services during the COVID-19 pandemic, growing trends of telehealth and telemedicine, rising demand for advanced point-of-care diagnostics, and increasing government and private funding for development of COVID-19 vaccines are other key factors driving market revenue growth. Furthermore, increasing investments in new drug discovery & development and rising government focus on reinforcing the healthcare supply chain to meet growing medical needs are factors boosting revenue growth of this market.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/blood-culture-tests-market
Table of Contents (ToC) – Global Blood Culture Tests Market
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.1. Primary Sources
1.4.2. Secondary Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2030
Chapter 3. Key Insights
Chapter 4. Global Pharma & Healthcare Market Segmentation
4.1. Global Pharma & Healthcare Market COVID-19 Impact Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.3. Market restraints analysis
4.3. Technological Insights
4.4. Porter’s Five Forces Analysis
4.5. Regulatory Framework
4.6. Price trend Analysis
4.7. Competitive Metric Space Analysis
Key Regional Markets Covered in the Report:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Spain, France, BENELUX, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of Asia Pacific)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1461
Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.
Get Explore Latest Research Report by Reports and Data:
Hematology Analyzers and Reagents Market @ https://www.prnewswire.com/news-releases/hematology-analyzers-and-reagents-market-to-reach-usd-12-10-billion-by-2027–reports-and-data-301121926.html
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]